Integrin alpha v beta 3 is a marker of progression in malignant melanoma. Previously we reported that human melanoma cells derived from regional lymph node metastases had increased alpha v beta 3-mediated adhesion to lymph node vitronectin. In the present study, the expression and function of alpha v beta 3 were further investigated with emphasis on the functional relationship between alpha v beta 3 and the urokinase-type plasminogen activator system of proteolysis. We found that metastases-derived melanoma MeWo LNI 6I (6I) and MIM/8 LNI cells had a markedly increased expression of alpha v mRNA transcripts relative to the parent lines which was reflected in significantly elevated levels of the alpha v beta 3 heterodimers on the cell surface. These cells also expressed elevated levels of urokinase plasminogen activator receptor (uPAR) mRNA and had higher levels of surface bound urokinase plasminogen activator as detected by immunolabeling. To determine whether the expression of uPAR and alpha v were linked, alpha v synthesis in the metastatic melanoma cells was suppressed using alpha v antisense phosphorothioate oligonucleotides. This resulted in a marked decrease in detectable alpha v mRNA and protein and a corresponding substratum-specific reduction in cell adhesion to vitronectin. When uPAR expression in these cells was subsequently analyzed, we found a reduction of approximately 50% in uPAR mRNA levels. On the other hand, ligation of the alpha v beta 3 receptor on the melanoma cells by immobilized antibody resulted in a twofold increase in uPAR mRNA. The results suggest that the expression of uPAR in metastatic melanoma cells is linked to the expression and function of the vitronectin receptor.
J Nip, S A Rabbani, H R Shibata, P Brodt
Title and authors | Publication | Year |
---|---|---|
Irisin and Metastatic Melanoma: Selective Anti-Invasiveness Activity in BRAF Wild-Type Cells
Serratì S, Zerlotin R, Manganelli M, Di Fonte R, Dicarlo M, Oranger A, Colaianni G, Porcelli L, Azzariti A, Guida S, Grano M, Colucci SC, Guida G |
International Journal of Molecular Sciences | 2025 |
Studies on primary uveal and cutaneous melanoma cell interaction with vitronectin: Melanoma cell interaction with vitronectin
ME Janik, A Lityńska, M Przybyło |
Cell Biology International | 2014 |
The cellular microenvironment modulates the role of PAI-1 and vitronectin in mediating cell-matrix interactions
S Goswami, LC Thompson, L Wickman, CB Peterson |
Advances in Biological Chemistry | 2013 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
Angiogenesis
TH Adair, JP Montani |
Colloquium Series on Integrated Systems Physiology: From Molecule to Function | 2010 |
DNA tumour viruses promote tumour cell invasion and metastasis by deregulating the normal processes of cell adhesion and motility
MA Morris, LS Young, CW Dawson |
European Journal of Cell Biology | 2008 |
Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels
R Navab, C Pedraza, L Fallavollita, N Wang, E Chevet, P Auguste, S Jenna, Z You, A Bikfalvi, J Hu, R O'Connor, A Erickson, JS Mort, P Brodt |
Oncogene | 2008 |
Plasminogen activators are involved in the degradation of bone by osteoclasts
V Everts, E Daci, W Tigchelaar-Gutter, KA Hoeben, S Torrekens, G Carmeliet, W Beertsen |
Bone | 2008 |
Expression of alpha V integrin is modulated by Epstein–Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors
T Choudhuri, SC Verma, K Lan, ES Robertson |
Virology | 2006 |
Modulation of the urokinase-type plasminogen activator receptor by the β6 integrin subunit
N Dalvi, GJ Thomas, JF Marshall, M Morgan, R Bass, V Ellis, PM Speight, SA Whawell |
Biochemical and Biophysical Research Communications | 2004 |
Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical Intervention
WG Jiang, RE Mansel |
2004 | |
Urokinase Receptor Modulates Cellular and Angiogenic Responses in Obstructive Nephropathy
G Zhang, H Kim, X Cai, JM Lopez-Guisa, P Carmeliet, AA Eddy |
Journal of the American Society of Nephrology : JASN | 2003 |
Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins
U Reuning, V Magdolen, S Hapke, M Schmitt |
Biological Chemistry | 2003 |
Angiogenesis in cutaneous melanoma: Pathogenesis and clinical implications
A Srivastava, R Ralhan, J Kaur |
Microscopy Research and Technique | 2003 |
Thrombospondin-1 and Cutaneous Melanoma
MJ Trotter, R Colwell, VA Tron |
Journal of Cutaneous Medicine & Surgery | 2003 |
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating ?v?5 vitronectin receptor cell surface expression
I Silvestri, IL Cattani, P Franco, G Pirozzi, G Botti, MP Stoppelli, MV Carriero |
International Journal of Cancer | 2002 |
Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences
Y Adachi, N Chandrasekar, Y Kin, SS Lakka, S Mohanam, N Yanamandra, PM Mohan, GN Fuller, B Fang, J Fueyo, DH Dinh, WC Olivero, T Tamiya, T Ohmoto, AP Kyritsis, JS Rao |
Oncogene | 2002 |
Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade
N Ahmed, F Pansino, R Clyde, P Murthi, MA Quinn, GE Rice, MV Agrez, S Mok, MS Baker |
Carcinogenesis | 2002 |
Urokinase-Receptor/Integrin Complexes Are Functionally Involved in Adhesion and Progression of Human Breast Cancer in Vivo
G der Pluijm, B Sijmons, H Vloedgraven, C der Bent, JW Drijfhout, J Verheijen, P Quax, M Karperien, S Papapoulos, C Löwik |
The American Journal of Pathology | 2001 |
The role of the plasminogen activation system in angiogenesis and metastasis
SA Rabbani, AP Mazar |
Surgical oncology clinics of North America | 2001 |
Down-regulation of Integrin α v β 3 Expression and Integrin-mediated Signaling in Glioma Cells by Adenovirus-mediated Transfer of Antisense Urokinase-type Plasminogen Activator Receptor ( uPAR ) and Sense p16 Genes
Y Adachi, SS Lakka, N Chandrasekar, N Yanamandra, CS Gondi, S Mohanam, DH Dinh, WC Olivero, M Gujrati, T Tamiya, T Ohmoto, G Kouraklis, B Aggarwal, JS Rao |
The Journal of biological chemistry | 2001 |
α v Integrin, p38 Mitogen-activated Protein Kinase, and Urokinase Plasminogen Activator Are Functionally Linked in Invasive Breast Cancer Cells
J Chen, C Baskerville, Q Han, ZK Pan, S Huang |
The Journal of biological chemistry | 2001 |
The Receptor for the Type I Insulin-like Growth Factor and its Ligands Regulate Multiple Cellular Functions That Impact on Metastasis
AA Samani, P Brodt |
Surgical oncology clinics of North America | 2001 |
Clinical significance of urokinase-type plasminogen activator activity in hepatocellular carcinoma
T Itoh, Y Hayashi, T Kanamaru, Y Morita, S Suzuki, W Wang, L Zhou, JA Rui, M Yamamoto, Y Kuroda, H Itoh |
Journal of Gastroenterology and Hepatology | 2000 |
Urokinase-type plasminogen activator up-regulates the expression of its cellular receptor
N Montuori, S Salzano, G Rossi, P Ragno |
FEBS Letters | 2000 |
Suppressive Mechanism of Salmosin, a Novel Disintegrin in B16 Melanoma Cell Metastasis
IC Kang, DS Kim, Y Jang, KH Chung |
Biochemical and Biophysical Research Communications | 2000 |
An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells
P A Townsend, I Villanova, E Uhlmann, A Peyman, J Knolle, R Baron, A Teti, M A Horton |
European Journal of Cancer | 2000 |
Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity
S Huang, L New, Z Pan, J Han, GR Nemerow |
The Journal of biological chemistry | 2000 |
Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of αv integrins
S Huang, D Stupack, A Liu, D Cheresh, GR Nemerow |
Oncogene | 2000 |
Regulation of urokinase plasminogen activator/plasmin- mediated invasion of melanoma cells by the integrin vitronectin receptor α V β 3: Regulation of uPAR-Mediated Invasion by α v β 3
AM Khatib, J Nip, L Fallavollita, M Lehmann, G Jensen, P Brodt |
International Journal of Cancer | 2000 |
Oligodeoxynucleotide Targeted to the αv Gene Inhibits αv Integrin Synthesis, Impairs Osteoclast Function, and Activates Intracellular Signals to Apoptosis
I Villanova, PA Townsend, E Uhlmann, J Knolle, A Peyman, M Amling, R Baron, MA Horton, A Teti |
Journal of Bone and Mineral Research | 1999 |
Degradation of Extracellular Matrix by Metastatic Follicular Thyroid Carcinoma Cell Lines: Role of the Plasmin Activation System
JW Smit, GV der Pluijm, HA Romijn, CW Löwik, H Morreau, BM Goslings |
Thyroid | 1999 |
Adenoviral Gene Transfer of β3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma
MY Hsu, DT Shih, FE Meier, PV Belle, JY Hsu, DE Elder, CA Buck, M Herlyn |
The American Journal of Pathology | 1998 |
Presidential address: Beyond risk groups—A new look at differentiated thyroid cancer
B Cady |
Surgery | 1998 |
Integrins take partners: cross-talk between integrins and other membrane receptors
JC Porter, N Hogg |
Trends in Cell Biology | 1998 |
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI
CN Rao, B Cook, Y Liu, K Chilukuri, MS Stack, DC Foster, W Kisiel, DT Woodley |
International Journal of Cancer | 1998 |
Proteases in cutaneous melanoma
CM Ferrier, GN van Muijen, DJ Ruiter |
Annals of Medicine | 1998 |
Urokinase type plasminogen activator receptor expression in colorectal neoplasms
S Suzuki, Y Hayashi, Y Wang, T Nakamura, Y Morita, K Kawasaki, K Ohta, N Aoyama, SR Kim, H Itoh, Y Kuroda, WF Doe |
Gut | 1998 |
Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma
MY Hsu, DT Shih, FE Meier, PV Belle, JY Hsu, DE Elder, CA Buck, M Herlyn |
The American Journal of Pathology | 1998 |
Expression of alphav integrins and vitronectin receptor identity in breast cancer cells
T Meyer, JF Marshall, IR Hart |
British Journal of Cancer | 1998 |
Suppression of Type I Collagenase Expression by Antisense RNA in Melanoma Cells Results in Reduced Synthesis of the Urokinase-Type Plasminogen Activator Receptor
M Durko, P Brodt |
Biochemical and Biophysical Research Communications | 1998 |
Characterization of the integrin αv gene promoter in mice
M Kambe, Y Miyamoto, M Hayashi |
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | 1998 |
Enhanced Invasion and Liver Colonization by Lung Carcinoma Cells Overexpressing the Type 1 Insulin-Like Growth Factor Receptor
L Long, R Rubin, P Brodt |
Experimental Cell Research | 1998 |
Growth Factor–dependent Activation of αvβ3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion
L Trusolino, G Serini, G Cecchini, C Besati, FS Ambesi-Impiombato, PC Marchisio, RD Filippi |
The Journal of Cell Biology | 1998 |
β 3 -Integrins Rather Than β 1 -Integrins Dominate Integrin-Matrix Interactions Involved in Postinjury Smooth Muscle Cell Migration
MJ Slepian, SP Massia, B Dehdashti, A Fritz, L Whitesell |
Circulation | 1998 |
Phosphorylation stabilizes alternatively spliced CD44 mRNA transcripts in breast cancer cells: inhibition by antisense complementary to casein kinase II mRNA
B Formby, R Stern |
Molecular and Cellular Biochemistry | 1998 |
Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system
A Stahl, BM Mueller |
International Journal of Cancer | 1997 |
Stereoisomere Peptid-Bibliotheken und Peptidmimetika zum Design von selektiven Inhibitoren des αv β3-Integrins für eine neuartige Krebstherapie
R Haubner, IH Kessler |
Angewandte Chemie | 1997 |
Dietary Coenzyme Q10 Supplementation Alters Platelet Size and Inhibits Human Vitronectin (CD51/CD61) Receptor Expression
VL Serebruany, JV Ordonez, WR Herzog, M Rohde, SA Mortensen, K Folkers, PA Gurbel |
Journal of Cardiovascular Pharmacology | 1997 |
Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor
SK Chintala, S Mohanam, Y Go, B Venkaiah, R Sawaya, ZL Gokaslan, JS Rao |
Molecular Carcinogenesis | 1997 |
Is Axillary Lymph Node Dissection Necessary in Routine Management of Breast Cancer? No
B Cady |
The Breast Journal | 1997 |
Advances in Molecular and Cell Biology
KJ Clemetson |
Advances in Molecular and Cell Biology | 1997 |
The α v β 3 Integrin Regulates α 5 β 1 -mediated Cell Migration toward Fibronectin
KO Simon, EM Nutt, DG Abraham, GA Rodan, LT Duong |
The Journal of biological chemistry | 1997 |
Role of Axillary Dissection in Mammographically Detected Breast Cancer
FR Jamali, SH Kurtzman, PJ Deckers |
Surgical oncology clinics of North America | 1997 |
Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues
Z Szekanecz, GK Haines, AE Koch |
Journal of clinical pathology | 1997 |
Up-regulated expression of the β3 integrin and the 92-kDa gelatinase in human HT-144 melanoma cell tumors grown in nude mice
V Gouon, GC Tucker, L Kraus-Berthier, G Atassi, N Kieffer |
International Journal of Cancer | 1996 |
Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradation
J Heino |
International Journal of Cancer | 1996 |
A polymeric form of fibronectin has antimetastatic effects against multiple tumor types
R Pasqualini, S Bourdoulous, E Koivunen, VL Woods, E Ruoslahti |
Nature Medicine | 1996 |
Integrin α3β1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma
NJ Tawil, V Gowri, M Djoneidi, J Nip, S Carbonetto, P Brodt |
International Journal of Cancer | 1996 |
The Plasminogen Activation System in Tumour Invasion and Metastasis
TJ Vries, GN Muijen, DJ Ruiter |
Pathology - Research and Practice | 1996 |
The role of the integrin vitronectin receptor, ?v?3 in melanoma metastasis
J Nip, P Brodt |
Cancer and Metastasis Reviews | 1995 |
Role of integrins and other cell adhesion molecules in tumor progression and metastasis
P Keely, L Parise, R Juliano |
Laboratory Investigation | 1993 |